AtriCure, Inc.
ATRCHealthcareNASDAQMedical Instruments & Supplies · Last scanned Jul 17, 2026
Scan Results
Daily timeframePart of the healthcare sector, AtriCure, Inc. (ATRC) is listed under Medical Instruments & Supplies. With a market capitalization of $1.80B, it sits in small-cap territory. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a single-use disposable RF products for the treatment of cardiac arrhythmias; cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; and EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation.
Market Cap
$1.80B
Beta
1.25
P/E (TTM)
—
P/E (Fwd)
102.15
EPS (TTM)
$-0.10
EPS (Fwd)
$0.35
ROE
-1.0%
ROA
-0.3%
Cash
$146.2M
Total Debt
$74.9M
Free CF
$41.1M
52W Change
19.7%
Annual Financials
Cash vs Debt
The balance sheet looks solid with $146.2M in cash comfortably exceeding the $74.9M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. The company generates $41.1M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of -1.0% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $330.4M (2022) to $534.5M (2025), reflecting a 62% increase over the period.
Investors considering AtriCure, Inc. should weigh the typical risks associated with ATRC's sector, size, and financial profile against their own risk tolerance and investment objectives. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for AtriCure, Inc. and its sector.